Home > PE Ratio > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
PE (Price/Earnings) Ratio

The Current P/E Ratio of MEDICAMEN BIOTECH is 47.17.

Share Price ₹416.8Apr 19,2024
Market Cap ₹529.3 Cr
Earnings-TTM₹11.2 CrTTM-Consolidated Results
Price/Earnings47.17xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of MEDICAMEN BIOTECH

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of MEDICAMEN BIOTECH is calculated as :

Current Market Cap [ ₹529.3 Cr] as on Apr 19,2024

(/) Earnings [ ₹11.2 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 47.17x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for MEDICAMEN BIOTECH , the investors are currently willing to pay 47.17 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MEDICAMEN BIOTECH !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of MEDICAMEN BIOTECH over the last five years.

Historical PE (Price/Earnings) ratio chart of MEDICAMEN BIOTECH


PE Ratio Performance Analysis for MEDICAMEN BIOTECH

- MEDICAMEN BIOTECH 's latest p/e ratio is 47.17x.

- MEDICAMEN BIOTECH 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 45.33x.

- MEDICAMEN BIOTECH 's operated at median p/e ratio of 52.79x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MEDICAMEN BIOTECH 's p/e ratio peaked in Mar2023 at 56.31x.

- MEDICAMEN BIOTECH 's p/e ratio hit its five-year low in Mar2020 of 16.61x.


How does MEDICAMEN BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
MEDICAMEN BIOTECH 11.2247.17529.3
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.60365,311.0
CIPLA LTD3,744.0329.01108,623.0
DR REDDYS LABORATORIES LTD5,209.4019.0399,134.3
ZYDUS LIFESCIENCES LTD2,954.2031.4192,794.9
DIVIS LABORATORIES LTD1,382.9770.4397,408.4
MANKIND PHARMA LTD1,743.3053.6793,565.4
TORRENT PHARMACEUTICALS LTD1,494.0057.4785,858.5
LUPIN LTD1,809.7438.9670,506.8
AUROBINDO PHARMA LTD2,777.8922.9363,697.4
ABBOTT INDIA LTD1,145.5848.4755,528.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MEDICAMEN BIOTECH 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.03x
Max industry PE 70.43x
Median industry PE 40.60x
Average industry PE 41.74x



You may also like the below Video Courses